Nabriva Therapeutics plc NBRV

Quarterly report 2023-Q1
added 05-22-2023

Nabriva Therapeutics plc DIO Ratio 2011-2026 | NBRV

Annual DIO Ratio Nabriva Therapeutics plc

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
154	282	1.55 K	3.56 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.56 K	154	1.39 K

Quarterly DIO Ratio Nabriva Therapeutics plc

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
192	-	179	-	409	-	279	240	10.9 K	-	21.3 K	1.44 K	37.1 K	-	4.15 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
37.1 K	179	7.61 K

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	CASI Pharmaceuticals CASI	47.4	-	-	$ 35.4 M	USA
	Завод ДИОД DIOD	768	-	-	-	Russia
	Фармсинтез LIFE	120	-	-	-	Russia
	Teligent, Inc. TLGT	198	-	-13.85 %	$ 16.1 M	USA
	AbbVie ABBV	91.6	$ 208.7	-0.07 %	$ 369 B	USA